Point72 Hong Kong Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2022$225,000
-63.4%
3,445
-37.8%
0.01%
-61.9%
Q1 2021$615,000
+128.6%
5,541
+79.4%
0.02%
-27.6%
Q3 2020$269,000
+171.7%
3,088
+257.4%
0.03%
+26.1%
Q4 2019$99,000
-23.8%
864
-16.4%
0.02%
-37.8%
Q3 2019$130,000
+4233.3%
1,034
+2694.6%
0.04%
+3600.0%
Q1 2019$3,000
-95.5%
37
-95.0%
0.00%
-95.7%
Q2 2018$67,000
+458.3%
747
+352.7%
0.02%
+283.3%
Q1 2018$12,000
+9.1%
165
-11.3%
0.01%
-25.0%
Q4 2017$11,000
-15.4%
186
-43.5%
0.01%
-42.9%
Q2 2017$13,000
-40.9%
329
-45.2%
0.01%
+16.7%
Q3 2016$22,0006000.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2019
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders